330 related articles for article (PubMed ID: 21165602)
1. Medical costs of osteoporosis in the elderly Medicare population.
Blume SW; Curtis JR
Osteoporos Int; 2011 Jun; 22(6):1835-44. PubMed ID: 21165602
[TBL] [Abstract][Full Text] [Related]
2. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
[TBL] [Abstract][Full Text] [Related]
3. The association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosis.
Halpern R; Becker L; Iqbal SU; Kazis LE; Macarios D; Badamgarav E
J Manag Care Pharm; 2011; 17(1):25-39. PubMed ID: 21204588
[TBL] [Abstract][Full Text] [Related]
4. Cost and management of males with closed fractures.
Brenneman SK; Yurgin N; Fan Y
Osteoporos Int; 2013 Mar; 24(3):825-33. PubMed ID: 22776864
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of a population-based osteoporosis intervention for outpatients with non-traumatic non-hip fractures: the "Catch a Break" 1i [type C] FLS.
Majumdar SR; Lier DA; Hanley DA; Juby AG; Beaupre LA;
Osteoporos Int; 2017 Jun; 28(6):1965-1977. PubMed ID: 28275838
[TBL] [Abstract][Full Text] [Related]
6. Association between osteoporosis treatment change and adherence, incident fracture, and total healthcare costs in a Medicare Advantage Prescription Drug plan.
Ward MA; Xu Y; Viswanathan HN; Stolshek BS; Clay B; Adams JL; Kallich JD; Fine S; Saag KG
Osteoporos Int; 2013 Apr; 24(4):1195-206. PubMed ID: 23100119
[TBL] [Abstract][Full Text] [Related]
7. Cost-effective osteoporosis treatment thresholds in Greece.
Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
[TBL] [Abstract][Full Text] [Related]
8. The burden of illness of osteoporosis in Canada.
Tarride JE; Hopkins RB; Leslie WD; Morin S; Adachi JD; Papaioannou A; Bessette L; Brown JP; Goeree R
Osteoporos Int; 2012 Nov; 23(11):2591-600. PubMed ID: 22398854
[TBL] [Abstract][Full Text] [Related]
9. Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy.
Viswanathan HN; Curtis JR; Yu J; White J; Stolshek BS; Merinar C; Balasubramanian A; Kallich JD; Adams JL; Wade SW
Appl Health Econ Health Policy; 2012 May; 10(3):163-73. PubMed ID: 22510025
[TBL] [Abstract][Full Text] [Related]
10. Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis.
Liu J; Guo H; Rai P; Pinto L; Barron R
Osteoporos Int; 2018 Nov; 29(11):2409-2417. PubMed ID: 30022254
[TBL] [Abstract][Full Text] [Related]
11. Projection of osteoporosis-related fractures and costs in China: 2010-2050.
Si L; Winzenberg TM; Jiang Q; Chen M; Palmer AJ
Osteoporos Int; 2015 Jul; 26(7):1929-37. PubMed ID: 25761729
[TBL] [Abstract][Full Text] [Related]
12. Age- and gender-specific epidemiology, treatment patterns, and economic burden of osteoporosis and associated fracture in Taiwan between 2009 and 2013.
Wang CY; Fu SH; Yang RS; Shen LJ; Wu FL; Hsiao FY
Arch Osteoporos; 2017 Oct; 12(1):92. PubMed ID: 29067572
[TBL] [Abstract][Full Text] [Related]
13. Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.
Pike C; Birnbaum HG; Schiller M; Swallow E; Burge RT; Edgell ET
Osteoporos Int; 2011 Jan; 22(1):47-56. PubMed ID: 20490782
[TBL] [Abstract][Full Text] [Related]
14. The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.
Chandran M; Lau TC; Gagnon-Arpin I; Dobrescu A; Li W; Leung MYM; Patil N; Zhao Z
Arch Osteoporos; 2019 Nov; 14(1):114. PubMed ID: 31773442
[TBL] [Abstract][Full Text] [Related]
15. Utilization and cost of anti-osteoporosis therapy among US Medicare beneficiaries.
Jha S; Bhattacharyya T
Arch Osteoporos; 2016 Dec; 11(1):28. PubMed ID: 27576482
[TBL] [Abstract][Full Text] [Related]
16. Declining trend in osteoporosis management and screening following vertebral compression fractures - a national analysis of commercial insurance and medicare advantage beneficiaries.
Malik AT; Retchin S; Phillips FM; Xu W; Peters K; Yu E; Khan SN
Spine J; 2020 Apr; 20(4):538-546. PubMed ID: 31683068
[TBL] [Abstract][Full Text] [Related]
17. Fracture Reduction Affects Medicare Economics (FRAME): impact of increased osteoporosis diagnosis and treatment.
King AB; Saag KG; Burge RT; Pisu M; Goel N
Osteoporos Int; 2005 Dec; 16(12):1545-57. PubMed ID: 15942702
[TBL] [Abstract][Full Text] [Related]
18. [Cost of fractures in German hospitals--what role does osteoporosis play?].
Bleibler F; Benzinger P; Lehnert T; Becker C; König HH
Gesundheitswesen; 2014 Mar; 76(3):163-8. PubMed ID: 23709102
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis in the European Union: a compendium of country-specific reports.
Svedbom A; Hernlund E; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA;
Arch Osteoporos; 2013; 8(1):137. PubMed ID: 24113838
[TBL] [Abstract][Full Text] [Related]
20. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
Hernlund E; Svedbom A; Ivergård M; Compston J; Cooper C; Stenmark J; McCloskey EV; Jönsson B; Kanis JA
Arch Osteoporos; 2013; 8(1):136. PubMed ID: 24113837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
